These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 24224121)

  • 1. Synergistic Effect of AJW200, a von Willebrand Factor Neutralizing Antibody with Low Dose (0.9 mg/mg) Thrombolytic Therapy Following Embolic Stroke in Rabbits.
    Lapchak PA; Doyan S; Fan X; Woods CM
    J Neurol Neurophysiol; 2013 Apr; 4(2):. PubMed ID: 24224121
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Ebselen, a seleno-organic antioxidant, is neuroprotective after embolic strokes in rabbits: synergism with low-dose tissue plasminogen activator.
    Lapchak PA; Zivin JA
    Stroke; 2003 Aug; 34(8):2013-8. PubMed ID: 12855833
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Neuroprotective effects of the spin trap agent disodium-[(tert-butylimino)methyl]benzene-1,3-disulfonate N-oxide (generic NXY-059) in a rabbit small clot embolic stroke model: combination studies with the thrombolytic tissue plasminogen activator.
    Lapchak PA; Araujo DM; Song D; Wei J; Zivin JA
    Stroke; 2002 May; 33(5):1411-5. PubMed ID: 11988623
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A novel method to promote behavioral improvement and enhance mitochondrial function following an embolic stroke.
    Lapchak PA; Boitano PD
    Brain Res; 2016 Sep; 1646():125-131. PubMed ID: 27180104
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A blinded, randomized study of L-arginine in small clot embolized rabbits.
    Lapchak PA; Daley JT; Boitano PD
    Exp Neurol; 2015 Apr; 266():143-6. PubMed ID: 25708986
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Microplasmin: a novel thrombolytic that improves behavioral outcome after embolic strokes in rabbits.
    Lapchak PA; Araujo DM; Pakola S; Song D; Wei J; Zivin JA
    Stroke; 2002 Sep; 33(9):2279-84. PubMed ID: 12215599
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The phenylpropanoid micronutrient chlorogenic acid improves clinical rating scores in rabbits following multiple infarct ischemic strokes: synergism with tissue plasminogen activator.
    Lapchak PA
    Exp Neurol; 2007 Jun; 205(2):407-13. PubMed ID: 17439814
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparison of Tenecteplase with Alteplase on clinical rating scores following small clot embolic strokes in rabbits.
    Lapchak PA; Araujo DM; Zivin JA
    Exp Neurol; 2004 Jan; 185(1):154-9. PubMed ID: 14697326
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Efficacy and safety profile of the carotenoid trans sodium crocetinate administered to rabbits following multiple infarct ischemic strokes: a combination therapy study with tissue plasminogen activator.
    Lapchak PA
    Brain Res; 2010 Jan; 1309():136-45. PubMed ID: 19891959
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pharmacology of caffeinol in embolized rabbits: clinical rating scores and intracerebral hemorrhage incidence.
    Lapchak PA; Song D; Wei J; Zivin JA
    Exp Neurol; 2004 Aug; 188(2):286-91. PubMed ID: 15246828
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Coadministration of NXY-059 and tenecteplase six hours following embolic strokes in rabbits improves clinical rating scores.
    Lapchak PA; Song D; Wei J; Zivin JA
    Exp Neurol; 2004 Aug; 188(2):279-85. PubMed ID: 15246827
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Simvastatin improves clinical scores in a rabbit multiple infarct ischemic stroke model: synergism with a ROCK inhibitor but not the thrombolytic tissue plasminogen activator.
    Lapchak PA; Han MK
    Brain Res; 2010 Jul; 1344():217-25. PubMed ID: 20493175
    [TBL] [Abstract][Full Text] [Related]  

  • 13. 3alpha-OL-5-beta-pregnan-20-one hemisuccinate, a steroidal low-affinity NMDA receptor antagonist improves clinical rating scores in a rabbit multiple infarct ischemia model: synergism with tissue plasminogen activator.
    Lapchak PA
    Exp Neurol; 2006 Feb; 197(2):531-7. PubMed ID: 16300757
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The lipophilic multifunctional antioxidant edaravone (radicut) improves behavior following embolic strokes in rabbits: a combination therapy study with tissue plasminogen activator.
    Lapchak PA; Zivin JA
    Exp Neurol; 2009 Jan; 215(1):95-100. PubMed ID: 18851964
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Adjuvant treatment with a glycoprotein IIb/IIIa receptor inhibitor increases the therapeutic window for low-dose tissue plasminogen activator administration in a rat model of embolic stroke.
    Zhang L; Zhang ZG; Zhang R; Morris D; Lu M; Coller BS; Chopp M
    Circulation; 2003 Jun; 107(22):2837-43. PubMed ID: 12756151
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Combination treatment with low-dose Niaspan and tissue plasminogen activator provides neuroprotection after embolic stroke in rats.
    Shehadah A; Chen J; Cui Y; Zhang L; Roberts C; Lu M; Chopp M
    J Neurol Sci; 2011 Oct; 309(1-2):96-101. PubMed ID: 21802695
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Neutrophil and Platelet Activity and Quantification Following Delayed tPA Therapy in a Rabbit Model of Thromboembolic Stroke.
    Bednar MM; Dooley RH; Zamani M; Howard DB; Gross CE
    J Thromb Thrombolysis; 1995; 1(2):179-185. PubMed ID: 10603528
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pharmacokinetics and pharmacodynamics of AJW200, a humanized monoclonal antibody to von Willebrand factor, in monkeys.
    Kageyama S; Yamamoto H; Nakazawa H; Matsushita J; Kouyama T; Gonsho A; Ikeda Y; Yoshimoto R
    Arterioscler Thromb Vasc Biol; 2002 Jan; 22(1):187-92. PubMed ID: 11788481
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Inhibition of PI3Kγ by AS605240 plus low-dose tissue plasminogen activator (tPA) combination improves thrombolytic therapy in a rat model of embolic stroke.
    Jin R; Zhong W; Liu S; Wang M; Li G
    Neurosci Lett; 2020 Nov; 738():135339. PubMed ID: 32882317
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The nonpeptide glycoprotein IIb/IIIa platelet receptor antagonist SM-20302 reduces tissue plasminogen activator-induced intracerebral hemorrhage after thromboembolic stroke.
    Lapchak PA; Araujo DM; Song D; Zivin JA
    Stroke; 2002 Jan; 33(1):147-52. PubMed ID: 11779904
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.